Grown Rogue International (GRUSF) Cash from Investing Activities (2011 - 2026)

Grown Rogue International's (GRUSF) quarterly Cash from Investing Activities came in at -$2.9 million in Q1 2026, down 761.12% year-on-year from $434808.6 in Q1 2025, and down 100.0% quarter-over-quarter from $1955.8 billion in Q4 2025.

Grown Rogue International (GRUSF) Cash from Investing Activities (2011 - 2026) Analysis & Trends

Grown Rogue International's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$2.9 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 761.12% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was $1955.8 billion, a 28569526.18% increase from a year earlier, with the FY2025 full-year figure at -$6.9 million, up 23.4% from the prior year.
  • Cash from Investing Activities fell to -$2.9 million in Q1 2026 per GRUSF's latest filing, from $1955.8 billion in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1955.8 billion in Q4 2025 and bottomed at -$2.9 million in Q1 2026.
  • The 5-year median for Cash from Investing Activities is -$1.4 million (2023), against an average of $163.0 billion.
  • Across the five-year window, Cash from Investing Activities surged 103863188.84% in 2025 and tumbled 761.12% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$455557.1 in 2022, then tumbled by 361.53% to -$2.1 million in 2023, then grew by 10.44% to -$1.9 million in 2024, then surged by 103863188.84% to $1955.8 billion in 2025, then sank by 100.0% to -$2.9 million in 2026.
  • Per Business Quant, the three latest GRUSF Cash from Investing Activities figures stand at -$2.9 million (Q1 2026), $1955.8 billion (Q4 2025), and -$333822.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 229.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 743.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -60.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -2.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.87 Mn
Mar 31, 2026 -2.87 Mn
Dec 31, 2025 1,955.77 Bn
Dec 31, 2025 1,955.77 Bn
Mar 31, 2025 -333,822.00
Mar 31, 2025 -333,822.00
Dec 31, 2024 -1.88 Mn
Dec 31, 2024 -1.88 Mn
Sep 30, 2024 -2.44 Mn
Sep 30, 2024 -2.44 Mn
Jun 30, 2024 -2.19 Mn
Jun 30, 2024 -2.19 Mn
Mar 31, 2024 -2.41 Mn
Mar 31, 2024 -2.41 Mn
Oct 31, 2023 -2.10 Mn
Oct 31, 2023 -2.10 Mn
Jul 31, 2023 -910,381.00
Jul 31, 2023 -910,381.00
Apr 30, 2023 -428,955.00
Apr 30, 2023 -428,955.00